Skip to main content
Clinical Trials/NCT00472212
NCT00472212CompletedNot Applicable

Correction of Hyperopia in Children Study

Ohio State University4 sites in 1 country58 target enrollmentStarted: November 1, 2003Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
58
Locations
4
Primary Endpoint
Change in Kaufman Test of Educational Achievement (K-TEA) Reading Comprehension Score as Measured From Baseline to After 6 Weeks of Assigned Treatment (Hyperopic or Control Correction)

Study Overview

Brief Summary

The Correction of Hyperopia In Children Study (CHICS) is a placebo-controlled, randomized, masked investigation of the effect of spectacle correction for moderate amounts of hyperopia on visual function, attention, and reading skills in children.

Detailed Description

Hyperopia (farsightedness) has been reported to be associated with reduced visual perceptual and reading abilities. However, there is controversy regarding whether or not to prescribe for low to moderate amounts of hyperopia. The Correction of Hyperopia In Children Study (CHICS) is a placebo-controlled, randomized, masked investigation of the effect of spectacle correction for moderate amounts of hyperopia on visual function, attention, and reading skills in children.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
6 Years to 11 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age 6-11 years;
  • •At least +1.00D Hyperopia (farsightedness);
  • •< +4.00D Hyperopia;
  • •< 1.00D Astigmatism;
  • •< 1.00D Anisometropia (difference between the two eyes);
  • •Willing to be randomized;
  • •Best corrected visual acuity of 20/25 or better in each eye;
  • •Willing to wear eyeglasses full-time;
  • •Willing to return for follow-up visits

Exclusion Criteria

  • •Previous wear of glasses or contacts for farsightedness/hyperopia;
  • •Eye disease that affects visual function;
  • •Amblyopia (lazy eye);
  • •Strabismus (eye turn);
  • •History of strabismus surgery;
  • •Chronic use of any of the following medications:
  • •Antianxiety agents (Librium, Valium)
  • •Antiarrythmic agents (Cifenline, Cibenzoline)
  • •Anticholinergics (Motion sickness patch - scopolamine)
  • •Bladder spasmolytic (Propiverine)
  • •Chloroquine
  • •Phenothiazines (Compazine, Mellaril, Thorazine)
  • •Tricyclic antidepressants (Elavil, Nortriptyline, Tofranil)

Arms & Interventions

Spectacles

Experimental

Spectacles with hyperopic lenses

Intervention: Spectacles (Device)

Control

Placebo Comparator

Spectacles with placebo lenses

Intervention: Control (Device)

Outcomes

Primary Outcomes

Change in Kaufman Test of Educational Achievement (K-TEA) Reading Comprehension Score as Measured From Baseline to After 6 Weeks of Assigned Treatment (Hyperopic or Control Correction)

Time Frame: 6 week outcome exam

The Kaufman Test of Educational Achievement (K-TEA) was used to measure change in reading skill (reading comprehension). The K-TEA is a well-established, individually administered, standardized test for assessment of achievement in reading, with a mean standard score of 100 and standard deviation of 15. Higher values represent better performance.

Secondary Outcomes

  • Change in Cognitive Assessment System (CAS) Attention Scores as Measured From Baseline to After 6 Weeks of Assigned Treatment (Hyperopic or Control Correction)(6 week outcome exam)
  • Change in Accommodative Response From Baseline to After 6 Weeks of Assigned Treatment (Hyperopic or Control Correction)(6 week outcome exam)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Marjean Kulp

Professor

Ohio State University

Study Sites (4)

Loading locations...

Similar Trials

Correction of Farsightedness in Children... | Clinical Trial